rs143695164

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_018723.4(RBFOX1):​c.96C>G​(p.Pro32Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000757 in 1,614,122 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 2 hom. )

Consequence

RBFOX1
NM_018723.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0640

Publications

1 publications found
Variant links:
Genes affected
RBFOX1 (HGNC:18222): (RNA binding fox-1 homolog 1) The Fox-1 family of RNA-binding proteins is evolutionarily conserved, and regulates tissue-specific alternative splicing in metazoa. Fox-1 recognizes a (U)GCAUG stretch in regulated exons or in flanking introns. The protein binds to the C-terminus of ataxin-2 and may contribute to the restricted pathology of spinocerebellar ataxia type 2 (SCA2). Ataxin-2 is the product of the SCA2 gene which causes familial neurodegenerative diseases. Fox-1 and ataxin-2 are both localized in the trans-Golgi network. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
RBFOX1 Gene-Disease associations (from GenCC):
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • autism susceptibility 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 16-7518215-C-G is Benign according to our data. Variant chr16-7518215-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 415962.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.064 with no splicing effect.
BS2
High AC in GnomAd4 at 84 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBFOX1NM_018723.4 linkc.96C>G p.Pro32Pro synonymous_variant Exon 5 of 16 ENST00000550418.6 NP_061193.2 Q9NWB1-1Q59HD3
RBFOX1NM_145893.3 linkc.156C>G p.Pro52Pro synonymous_variant Exon 2 of 14 ENST00000355637.9 NP_665900.1 Q9NWB1-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBFOX1ENST00000550418.6 linkc.96C>G p.Pro32Pro synonymous_variant Exon 5 of 16 1 NM_018723.4 ENSP00000450031.1 Q9NWB1-1
RBFOX1ENST00000355637.9 linkc.156C>G p.Pro52Pro synonymous_variant Exon 2 of 14 1 NM_145893.3 ENSP00000347855.4 Q9NWB1-5

Frequencies

GnomAD3 genomes
AF:
0.000559
AC:
85
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000779
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000801
AC:
201
AN:
250882
AF XY:
0.000892
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000608
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000786
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000778
AC:
1138
AN:
1461832
Hom.:
2
Cov.:
31
AF XY:
0.000835
AC XY:
607
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33478
American (AMR)
AF:
0.000559
AC:
25
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000803
AC:
21
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00285
AC:
246
AN:
86240
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53420
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.000693
AC:
771
AN:
1111984
Other (OTH)
AF:
0.000795
AC:
48
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
67
134
200
267
334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000552
AC:
84
AN:
152290
Hom.:
0
Cov.:
32
AF XY:
0.000457
AC XY:
34
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41582
American (AMR)
AF:
0.000588
AC:
9
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4824
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000779
AC:
53
AN:
68016
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000848
Hom.:
0
Bravo
AF:
0.000518
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000533

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RBFOX1: BP4, BP7, BS1 -

Mar 12, 2018
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
5.7
DANN
Benign
0.80
PhyloP100
0.064
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143695164; hg19: chr16-7568217; API